Ibrahim N - Search Results

1

Treatment With Etirinotecan Pegol for Patients With Metastatic Breast Cancer and Brain Metastases: Final Results From the Phase 3 ATTAIN Randomized Clinical Trial.

Tripathy D, Tolaney SM, Seidman AD, Anders CK, Ibrahim N, Rugo HS, Twelves C, Diéras V, Müller V, Du Y, Currie SL, Hoch U, Tagliaferri M, Hannah AL, Cortés J; ATTAIN Investigators. Tripathy D, et al. Among authors: ibrahim n. JAMA Oncol. 2022 Jul 1;8(7):1047-1052. doi: 10.1001/jamaoncol.2022.0514. JAMA Oncol. 2022. PMID: 35552364 Free PMC article. Clinical Trial.

2

Paclitaxel-containing combination chemotherapy for metastatic breast cancer.

Hortobagyi GN, Ibrahim N. Hortobagyi GN, et al. Among authors: ibrahim n. Semin Oncol. 1996 Feb;23(1 Suppl 1):53-7. Semin Oncol. 1996. PMID: 8629039

3

Doxorubicin-based chemotherapy in elderly patients with metastatic breast cancer. Tolerance and outcome.

Ibrahim NK, Frye DK, Buzdar AU, Walters RS, Hortobagyi GN. Ibrahim NK, et al. Arch Intern Med. 1996 Apr 22;156(8):882-8. Arch Intern Med. 1996. PMID: 8774207

4

The University of Texas M.D. Anderson Cancer Center experience with paclitaxel in breast cancer.

Hortobagyi GN, Holmes FA, Ibrahim N, Champlin R, Buzdar AU. Hortobagyi GN, et al. Among authors: ibrahim n. Semin Oncol. 1997 Feb;24(1 Suppl 3):S30-3. Semin Oncol. 1997. PMID: 9071338 Review.

5

Doxorubicin-induced congestive heart failure in elderly patients with metastatic breast cancer, with long-term follow-up: the M.D. Anderson experience.

Ibrahim NK, Hortobagyi GN, Ewer M, Ali MK, Asmar L, Theriault RL, Fraschini G, Frye DK, Buzdar AU. Ibrahim NK, et al. Cancer Chemother Pharmacol. 1999;43(6):471-8. doi: 10.1007/s002800050926. Cancer Chemother Pharmacol. 1999. PMID: 10321507

6

Prospective evaluation of paclitaxel versus combination chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide as neoadjuvant therapy in patients with operable breast cancer.

Buzdar AU, Singletary SE, Theriault RL, Booser DJ, Valero V, Ibrahim N, Smith TL, Asmar L, Frye D, Manuel N, Kau SW, McNeese M, Strom E, Hunt K, Ames F, Hortobagyi GN. Buzdar AU, et al. Among authors: ibrahim n. J Clin Oncol. 1999 Nov;17(11):3412-7. doi: 10.1200/JCO.1999.17.11.3412. J Clin Oncol. 1999. PMID: 10550135 Clinical Trial.

7

Colitis associated with docetaxel-based chemotherapy in patients with metastatic breast cancer.

Ibrahim NK, Sahin AA, Dubrow RA, Lynch PM, Boehnke-Michaud L, Valero V, Buzdar AU, Hortobagyi GN. Ibrahim NK, et al. Lancet. 2000 Jan 22;355(9200):281-3. doi: 10.1016/S0140-6736(99)06195-4. Lancet. 2000. PMID: 10675076 Clinical Trial.

8

Phase I study of vinorelbine by 96-hour infusion in advanced metastatic breast cancer.

Ibrahim NK, Valero V, Theriault RL, Willey J, Walters RS, Buzdar AU, Booser DJ, Hortobagyi GN. Ibrahim NK, et al. Am J Clin Oncol. 2000 Apr;23(2):117-21. doi: 10.1097/00000421-200004000-00003. Am J Clin Oncol. 2000. PMID: 10776969 Clinical Trial.

9

Doxorubicin-based adjuvant chemotherapy in elderly breast cancer patients: the M.D. Anderson experience, with long-term follow-up.

Ibrahim NK, Buzdar AU, Asmar L, Theriault RL, Hortobagyi GN. Ibrahim NK, et al. Ann Oncol. 2000 Dec;11(12):1597-601. doi: 10.1023/a:1008315312795. Ann Oncol. 2000. PMID: 11205469 Free article.

10

Phase I study of vinorelbine and docetaxel with granulocyte colony-stimulating factor support in the treatment of metastatic breast cancer.

Ibrahim NK, Rahman Z, Valero V, Murray JL 3rd, Frye D, Hortobagyi GN. Ibrahim NK, et al. Cancer Invest. 2002;20(1):29-37. doi: 10.1081/cnv-120000363. Cancer Invest. 2002. PMID: 11852999 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,860 results

Search Page